Qube Research & Technologies (QRT)
LFST icon

Qube Research & Technologies (QRT)’s Lifestance Health LFST Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.87M Sell
828,268
-2,360,389
-74% -$18.2M 0.01% 1352
2026
Q1 		$20.3M Buy
3,188,657
+508,970
+19% +$3.54M 0.02% 876
2025
Q4 		$18.9M Sell
2,679,687
-202,731
-7% -$1.22M 0.02% 948
2025
Q3 		$15.9M Buy
2,882,418
+427,391
+17% +$2.09M 0.02% 1023
2025
Q2 		$12.7M Buy
2,455,027
+1,166,045
+90% +$6.99M 0.01% 1149
2025
Q1 		$8.58M Buy
1,288,982
+1,203,797
+1,413% +$9.15M 0.01% 1227
2024
Q4 		$628K Buy
+85,185
New +$611K ﹤0.01% 2372
2022
Q2 		– Sell
-62,737
Closed -$634K – 2861
2022
Q1 		$634K Buy
+62,737
New +$551K 0.01% 1409
2021
Q3 		– Sell
-10,864
Closed -$303K – 2526
2021
Q2 		$303K Buy
+10,864
New +$287K ﹤0.01% 1575

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LFST Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Lifestance Health (LFST) stake by 74% in Q2 2026, selling an estimated $18.2M and leaving 828,268 shares worth $8.87M. The position accounts for 0.01% of the portfolio, ranked #1352.

Qube Research & Technologies (QRT) first reported a position in LFST in Q2 2021 and has held it in 9 quarters since. The position peaked at $20.3M in Q1 2026. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Qube Research & Technologies (QRT) held 828,268 shares of Lifestance Health worth $8.87M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 2,360,389 Lifestance Health shares in Q2 2026, an estimated $18.2M.
  • Lifestance Health made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1352 holding.
  • Qube Research & Technologies (QRT) first reported a position in Lifestance Health in Q2 2021 and has held it in 9 quarters since.
  • Qube Research & Technologies (QRT)'s Lifestance Health position peaked at $20.3M in Q1 2026.
  • 288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.